Business Paid
Polish biotech Ryvu Therapeutics with a €3.94 mln deal for clinical trial drug
13:39
Ryvu Therapeutics has entered into an agreement with Clinical Services International to secure the supply chain of the drug venetoclax for the clinical trial RIVER-81. The contract's total value will be approximately €3.94 million.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
